Navigation Links
Northfield Laboratories Investor Update

quate supplies of raw materials and to manufacture PolyHeme in commercial quantities, our ability to market PolyHeme successfully, the possibility that competitors will develop products that will render PolyHeme obsolete or non-competitive, our ability to protect our intellectual property rights, the outcome of certain governmental inquiries and purported class action lawsuit as described in our most recently filed annual report on Form 10-K and quarterly report on Form 10-Q, the possibility that we may be subject to product liability claims and other legal actions, our dependency on a limited number of key personnel, the uncertainty of third party reimbursement for our product and other risks and uncertainties described from time to time in our periodic reports filed with the Securities and Exchange Commission, including our most recently filed annual report on Form 10-K and quarterly report on Form 10-Q. These forward-looking statements speak only as of the date of this press release. We do not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the time such statement is made. All subsequent written and oral forward-looking statements attributable to Northfield or any person acting on our behalf are qualified by this cautionary statement.

Contact

Northfield Laboratories Inc.
Sophia H. Twaddell, 847-864-3500
Vice President, Corporate Communications
stwaddell@northfieldlabs.com
or
Fleishman-Hillard
Tom Laughran, 312-751-3519
tom.laughran@fleishman.com


'"/>




Page: 1 2

Related medicine technology :

1. Northfield Laboratories Reports Results of Pivotal Phase III Trauma Study
2. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
3. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study for Milnacipran as a Treatment for Fibromyalgia Syndrome
4. Columbia Laboratories Reports Preliminary Findings from the Ongoing Data Analysis of the Phase III Clinical Study of PROCHIEVE 8% (progesterone gel) to Prevent Preterm Birth
5. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
6. Review of Nexavar Data Presented at ASCO 2007- Investor Conference Call on June 4, 2007
7. Acorda Therapeutics to Host Analyst and Investor Reception
8. Isis Pharmaceuticals Announces Its Participation at the Upcoming ACC 56th Annual Scientific Session in New Orleans and Its Live Analyst/Investor Webcast Presentation
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Avexas Apricitabine Clinical Trial Update
11. Avalon Updates the AVN944 Phase I Hematologic Malignancies Trial
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Northfield Laboratories Investor Update
(Date:5/22/2013)... 2013  Aribex, Inc., manufacturer of the newly released ... new color option, black with gray trim, of the ... markets. The popular white with light blue trim Pro ... be available and both models can be purchased from ... http://photos.prnewswire.com/prnh/20130522/CL19573 ) "Dental offices are adding ...
(Date:5/22/2013)... May 22, 2013 Attorney Advertising -- Bronstein, ... on behalf of purchasers of the securities of ... AMAG -News).  The investigation focuses on whether the ... On May 22, 2013, Shares of ... after the company announced in regulatory filing that ...
(Date:5/22/2013)... and CAESAREA, Israel , May ... , New clinical data presented from the DEFLECT-I study ... Device reduces brain lesion volume during TAVR (Transcatheter Aortic ... Keystone Heart Scientific Advisory Board announces consensus on ... rising regarding the importance and need for cerebral protection ...
Breaking Medicine Technology:Aribex Unveils New Color of NOMAD Pro 2 2Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 3New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 4
... study published today in the,journal Current Medical ... superior to Cymbalta®,(duloxetine) in the acute treatment ... was at least as efficacious in,long-term treatment. ... reuptake inhibitor - ASRI) to duloxetine (a,serotonin ...
... - Both co-primary endpoints, Wake After Sleep Onset and ... Sleep, were met at both doses - Evotec to ... 10am EST) today , HAMBURG, Germany | OXFORD, England, ... today positive top-line,results from its first phase II clinical ...
Cached Medicine Technology:Cipralex demonstrates superiority to duloxetine for acute treatment,of depression in new study 2Cipralex demonstrates superiority to duloxetine for acute treatment,of depression in new study 3Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 2Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 3Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 4
(Date:5/23/2013)... Platinum Supplemental Insurance recently promoted Mary ... started her Platinum sales career in 2011. Her commitment ... of sales representatives selling Platinum products. , Platinum markets ... of rural communities. Satterlee is in charge of a ... help farmers prepare for the future in the event ...
(Date:5/23/2013)... Francisco, CA (PRWEB) May 23, 2013 ... safety outreach program being tackled by the Safe Passage ... second Fullpower personal safety workshop for women ... and teaches personal safety skills programs for people of ... telling us their experiences with street harassment for years,” ...
(Date:5/23/2013)... May 23, 2013 Fresh Healthy Vending ... machines stocked with healthy food and drinks in locations ... company’s in-house, full-service marketing and advertising department has a ... the media for their franchisees, and to promote the ... been featured in many leading publications and TV networks ...
(Date:5/23/2013)... 2013 Registered Dietitian and Founder of ... today on Tatalou.com offering helpful tips for travelers who ... titled “ How to Stay Healthy While Traveling ,” ... sanitizer, when it’s safe to drink the water when ... importance of staying hydrated and how taking health supplements ...
(Date:5/23/2013)... May 23, 2013 Teen birth rates declined ... to new data released today by the CDC’s ... teen birth rate dropped at least 15% in 48 states ... There were also dramatic declines among all racial/ethnic groups as ...     Birth rates declined 40% or more for Hispanic teens in ...
Breaking Medicine News(10 mins):Health News:Platinum Supplemental Insurance Promotes Mary Satterlee to Sales Team Leader 2Health News:San Francisco Tenderloin Women Say “No!” to Street Harassment: Safe Passage Sponsors Kidpower Adult Safety Skills Workshops and Resources 2Health News:San Francisco Tenderloin Women Say “No!” to Street Harassment: Safe Passage Sponsors Kidpower Adult Safety Skills Workshops and Resources 3Health News:San Francisco Tenderloin Women Say “No!” to Street Harassment: Safe Passage Sponsors Kidpower Adult Safety Skills Workshops and Resources 4Health News:Fresh Healthy Vending Receives Recent National and Local Media Focus 2Health News:How to Stay Healthy While Traveling 2
... America,s Future co-director Roger Hickey , Economic Policy ... Economic and Policy Research co-director Dean Baker ... President Obama ,s summit today on the nation,s future ... LAWRENCE MISHEL We applaud President ...
... Feb. 23 The non-profit LENA(TM) Foundation, which develops ... language disorders, has released two case studies showing how ... autism treatment. The LENA software enables the clinician ... turns at 5-minute and hourly intervals over the course ...
... eFoodSafety.com, Inc., (OTC Bulletin Board: EFSF) an emerging ... dermatology, environmental and nutraceutical products, today announced that Martin ... future Chairman and CEO of eFoodSafety.com, has purchased stock ... total of 100,000 shares in the open market on ...
... in Phoenix to Focus on Catheter Reduction and ... SEGUNDO, Calif., Feb 23 DaVita Inc., a ... 2009 Clinical Priorities to its partnering nephrologists during ... of the largest gatherings of nephrologists of the ...
... Practices provide guidance for healthcare systems in ... and community engagementWASHINGTON, Feb. 23 The ... to improving healthcare quality, has endorsed 45 ... care that is culturally appropriate and patient-centered. ...
... 23 Vanda Pharmaceuticals Inc. (Nasdaq: ... statement regarding two letters sent to Vanda by Tang Capital ... its intent to, among other things, nominate two directors to ... and submit proposals at the 2009 Annual Meeting to amend ...
Cached Medicine News:Health News:Progressive Leaders at White House Summit Today Underscore Need for Health Care Reform 2Health News:LENA Foundation Technology Measures Effectiveness of Autism Therapy 2Health News:LENA Foundation Technology Measures Effectiveness of Autism Therapy 3Health News:eFoodSafety.com Announces Open Market Stock Purchase by Management 2Health News:DaVita Releases Top Clinical Priorities for 2009 2Health News:DaVita Releases Top Clinical Priorities for 2009 3Health News:National Quality Forum Endorses Guidelines to Reduce Disparities in Healthcare and Make Care Patient-Centered and Culturally Appropriate 2Health News:National Quality Forum Endorses Guidelines to Reduce Disparities in Healthcare and Make Care Patient-Centered and Culturally Appropriate 3Health News:Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP 2Health News:Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP 3Health News:Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP 4Health News:Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP 5Health News:Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP 6
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: